Gary Oldman, Evangeline Lilly, & Armie Hammer to star in Dreamland
Academy Award-winning actor Gary Oldman (Darkest Hour) and Golden Globe-nominees Evangeline Lilly (Ant Man and the Wasp) and Armie Hammer (Call Me By Your Name) will star in director Nicholas Jarecki’s opiods-centered thriller Dreamland. In addtion, German actress Veronica Ferres has also joined the cast.
RELATED:Rebecca Hall to Star in Night House Horror Thriller from David S. Goyer
“The devastating impact of the opioid crisis reaches all corners of society,” Jarecki said in a statement. “Gary, Armie and Evangeline are the perfect performers to bring the human face of this epidemic to audiences everywhere.”
Written by Jarecki, Dreamland will follow three colliding stories about the international opiod crisis: a drug trafficker arranges a multi-cartel fentanyl smuggling operation between Canada and the U.S., an architect recovering from an OxyContin addiction tracks down the truth behind her son’s involvement with narcotics, and a university professor battles unexpected revelations about his research employer, a drug company with deep government influence bringing a new “non-addictive” painkiller to market— all in a thinking person’s gangster tale of high and low.
RELATED: The Chain: Jamie Bell, Margaret Qualley to Star in Adaptation
The film will be produce by Jarecki, and Cassian Elwes through their Green Room Films banner. Michael Suppes, Tony Hsieh, Douglas Urbanski, Mohammed Al Turki, Lisa Wilson, William Rosenfeld and Sam Slater along with Kean Cronin, Robert Kapp and Samuel Reich will all be serving as executive producers.
The film is a co-production between Green Room Films, Tuesday Films, Matisse Pictures, Construction Film and Burn Later Productions. It is also a Canadian-Begian production of Les Productions LOD in partnership of Bideford Productions. Principal Photography is currently happening in Montreal and Detroit.
(Photo credit: Getty Images)
The post Gary Oldman, Evangeline Lilly, & Armie Hammer to Star in Dreamland appeared first on ComingSoon.net.
0 comments: